Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. (Q54465171)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrew M. Wardley

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tadeusz Pieńkowski

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

object named as

Janusz Rolski

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

28

object named as

Matthieu Rupin

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

7

object named as

John Glaspy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tommy Fornander

10

object named as

Tommy Fornander

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jean-Paul Guastalla

5

object named as

Jean-Paul Guastalla

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Amer Sami

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Eva Juhos

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Robert Coleman

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Manuel R Modiano

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jeferson Vinholes

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tamas Pinter

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Alvaro Rodríguez-Lescure

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Bruce Colwell

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Pierre Whitlock

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Louise Provencher

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kara Laing

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

David Walde

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chris Price

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Judith C Hugh

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Barrett H Childs

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kimberly Bassi

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mary-Ann Lindsay

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Véronique Wilson

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Vincent Houé

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Charles Vogel

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

TRIO/BCIRG 001 investigators

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

John Hainsworth

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

12 December 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

72-80

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant docetaxel for node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant docetaxel for high-risk, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Influences of hypertension and diabetes on normal age-related changes in left ventricular function as assessed by tissue Doppler echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early breast cancer therapy and cardiovascular injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 and responsiveness of breast cancer to adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifactorial approach to predicting resistance to anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970525-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70525-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23246022%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54465171&oldid=1898842456"